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the immunoglobulin (Ig) super family comprises the broadest ranges of molecules, such as immunoglobulins (Igs), T cell receptors, major histocompatibility complex (MHC) class I antigens, MHCclass II antigens, Thy-1, N-CAM, CD4 and CD8 (6, 24) . By screening a CDNA expression library constructed from embryonal Cells and tumors. Teratocarcinoma OTT6050 (22) and N4-1 EC cells (18) were propagated in 129/Sv mice as embryoid bodies and solid tumors, respectively. Mouse EC cell line F9 (1) was cultured in Dulbecco's modified Eagle's minimal essential medium containing 15%fetal calf serum (FCS) under 12% CO2 at 37°C. Human normal diploid cell line WI-38 (4) and human gastric cancer cell line KATO-III (20) were cultured in Eagle's minimal essential mediumwith Earle's salts containing 10% FCS and RPMI-1640 containing 10% FCS, respectively. They were grown under 5%CO2 at 37°C.
Probes. An EcoRI-AccI fragment (nucleotide number -24-792 in Fig. 9 ) of pFR27, one of basigin CDNAclones and Pstl-AccI fragment (nucleotide number 102-792 in Fig. 9 ) of pFRl (12) were labeled by [a-32P]dCTP using a random oligonucleotide priming method (3) and used as probes for Southern blot hybridization and Northern blot hybridization, respectively. The EcoRI-PstI fragment (nucleotide number -24-101 in Fig. 9 ) and EcoRI-AccI fragment of pFR27 were labeled using the same method and used as probes for the screening of the igtll CDNAlibrary of OTT6050. DNAandRNAanalysis. DNAwas isolated from the liver of BALB/Cmouse and the liver of hamster as described by Blin and Stafford (2) . Human DNAwas isolated from peripheral leucocytes of a 31-year-old healthy male according to the method of Kunkel et al. (8) Southern blotting was performed as described by Southern (21) . Southern blots were prehybridized for 3 h in prehybridization solution [50% deionized formamide, 5 x SSC, 50 mM sodium phosphate, pH 6.5, 200^g/ml of heat-denatured salmon sperm DNA,10 x Denhardt's solution and 0.1% SDS] at 42°C and hybridized for 20h with the probe described above at 0.5-2.0 x 107 cpm/ml under conditions identical to those used for prehybridization. The membrane was washed with three changes of 2xSSC, 0.1% SDS at room temperature followed by three successive washes in 0.1 x SSC, 0.1% SDS at 55°C. RNAwas prepared by the guanidium isothiocyanate/cesium chloride method (1 1). For Northern blotting analysis, RNAwas denatured with glyoxal, separated on a 1% agarose gel and transferred to nitrocellulose membrane in 20 x SSC. The membrane was baked for 2 h under vacuum at 80°C and treated in 20 mMTris-HCl buffer, pH 8.0 at 100°C for 5 min. RNAblots were prehybridized for 3 h at 35°C in the same prehybridization solution used in the Southern blot hybridization and hybridized for 20 h at 35°C in the prehybridization solution containing the probe described above. The membranewas washed with three changes of 2x SSC, 0.1% SDSat room temperature followed by three successive washes in the same solution at 50°C. The DNA sequence was determined by the dideoxy chain termination method (17) after subcloning into pUC8 or pUC18. Isolation and Analysis of Glycoproteins. Glycoproteins binding to Lotus tetragonolobus agglutinin (LTA) were isolated by affinity chromatography from N4-1 EC cells as described by Kamada et al. The specificity of the immunological reaction was confirmed as before (12): the reaction was inhibited by the membranefraction from E. coli BNN103 (iFRl) which has a basigin insert, but not by the membrane fraction from E. coli BNN97.
Deglycosylation of glycoproteins. LTA receptors prepared from N4-1 tumors were boiled for 3 min in the presence of 0.5% SDS and 0.1 M^-mercaptoethanol. The denatured glycoproteins were diluted with 0.2 Msodium phosphate buffer, pH 8.6, 10mM1, 10-phenanthroline and 1.25% NP-40. N-Glycanase (Genzyme Co.) (5) and several drops of toluene were added to the reaction mixture and incubated at 37°C for 24 h. The reaction mixture was subjected to trichloroacetic acid precipitation followed by ethanol precipitation. The deglycosylated glycoproteins were analyzed electrophoretically, as described above, with the exception of using a 12% running gel. Screening of Igtll CDNAlibrary. The igtll library constructed from mRNAof teratocarcinoma OTT6050 (16) was screened by the plaque hybridization method (ll) using the probes described above. Primer extension. A 30-mer primer (2.5 ng), which was complementary to nucleotides 106-135 of the common sequence of basigin CDNA( Fig. 9 ) and was synthesized using a gene assembler (Pharmacia), was hybridized with 5 jug of poly(A)+RNA from teratocarcinoma OTT6050and extended with 100 units of reverse transcriptase, and the second strand was synthesized using ribonuclease H and DNApolymerase I (14) . Phosphorylated EcoRI linkers were ligated to the bluntended and methylated cDNAs, which were then digested with EcoRI and ligated to igtlO arms. The phage DNAwas packaged in vitro. The EcoRI-AccI fragment of pFR27 CDNAwas used as a probe for screening of the igtlO library by plaque hybridization.
RESULTS
Southern blot analysis of basigin gene. DNAfrom BALB/Cmice was digested with restriction enzymes and the fragments were analyzed by Southern blotting (Fig. 1 ). Three bands (30 kb, 13 kb and 3.0 kb) reacting with the basigin probe were detected in EcoRI digest. A broad band (5.2 kb) and a faint band (8.3 kb) were revealed in Sad digest; a broad band (12 kb) was present in AccI digest. These relatively simple profiles of restriction fragments of the basigin gene imply that the basigin gene is present as a single copy or a few copies per hamster is present as a single copy (Fig. 2 ).
The basigin probe also reacted with DNAfragments released from humanDNA,although the bands were broad and smears were detected (Fig. 3) gin. LTA receptors (100jug as proteins) isolated from N4-1 tumors were denatured by boiling in the presence of 0.5% SDS and O.l M f mercaptoethanol followed by incubation in the reaction mixture with or without 40 units/ml of N-glycanase at 37°C for 24 h. The reaction mixture was subjected to trichloroacetic acid precipitation followed by ethanol precipitation, then separated by SDS-PAGEon a 12% gel under reducing conditions. Separated proteins were transferred to a nitrocellulose membraneand reacted with antiserum against the fusion protein produced by^FRL The antiserum was preabsorbed with the membrane fraction of BNN97,as described by Miyauchi et al. ates, the molecular weight of basigin was indeed reduced to 32,000 (Fig. 5, lane 2) . There are still differences of molecular weight of about 4,000 between the observed molecular weight of deglycosylated basigin and the predicted molecular weight of basigin polypeptide devoid of the signal sequence. However, this small difference can be easily explained by O-glycosylation or phosphorylation. Thus, the present result confirmed the open reading frame of basigin. Furthermore, the enormousdifference between the size of intact basigin and the size of the deglycosylated one indicates that basigin is a heavily glycosylated molecule. Although the predicted N-glycosylation site in the extracellular domain of basigin is 3, the glycan portion with developmentalr egulated markers is large with a poly-N-acetyllactosamine backbone.
Basigin molecules from organs of adult mice. Basigin mRNAis detected in various organs of adult mice. However, the expression of mRNA does not always lead to intense expression of the polypeptide. In the case of carcinoembryonic antigen, which is also a member of the immunoglobulin super family, its mRNA is expressed in various normal tissues. The stability of the gene product determines its preferential expression in cancer tissues. Thus, we examined whether high levels of the basigin molecule are expressed in organs of adult mice. For that purpose, glycoproteins, which were enriched by affinity chromatography on RCA-I agarose or on Con A agarose, were analyzed by SDSpolyacrylamide gel electrophoresis and stained by anti- Met Ala Ala Ala Leu Leu Leu Ala Leu sequence of basigin typel~~"~s equence of basigin typeH -93 à"à"aefà"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"à"TTC CAA CAG CAG ACC TCA CAG AGT GGG GCT GAC -61
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Arg Pro Ala Pro Ala Ala Ala Pro Pro Pro Cys Arg Leu (typem) (Fig. 8) . The type II clone differed from the type I clone only in 39 base pairs in the 5'region (Fig. 9 ). This nucleotide difference results in differences of the N-terminal amino acid sequence of the basigin molecule. Among13 amino acids unique for the type II molecule, 10 were hydrophobic ones.
The CDNA sequence of basigin type II was incomplete and lacked the initiator ATG. Thus, we constructed a >?gtlO library from teratocarcinoma OTT6050 using synthetic primer corresponding to nucleotides 106-135 of basigin CDNA (Fig. 8, Fig. 9 ). By screening 5 x 104 plaque-forming units, 12 CDNAclones of basigin were obtained. Amongthem, only one clone had an insert large enough to cover the additional 5' sequence (250 base insert). The remainder had medium-sized inserts (220-230 base insert) or short inserts (140-150 base insert). Thus, we determined the sequences of the clone with the long insert, 2 clones with medium-size inserts and 2 clones with short inserts. Unexpectedly, the sequence of the long insert was different from both type I and type II, and was named type III (Fig. 9) . Twentyone nucleotides in the 3'-terminal side of the insert (nucleotide number -21 to -1) were commonto those in type I, and the rest were different. The type III insert coded 31 amino acids, of which 15 were hydrophobic. The mediumand small inserts had type I structure. As above, among the 12 CDNAclones sequenced, 4 clones had sequences different from the published basigin sequence (type I). Although there is little doubt that type I corresponds to the predominant basigin molecule, the occurrence of cDNAswith different 5' sequences in significant frequency suggests that somebasigin molecules have different N-terminal structures.
DISCUSSION
Basigin mRNA is detected in a variety of cells and organs (12). The result of the present investigation established the broad distribution of basigin at the protein level. Even though basigin is broadly distributed, the basigin structure is diverse. N-glycanase digestion has verified that basigin is a heavily glycosylated moleucle.
Basigin from EC cells is polydisperse, and the major component has a molecular weight of 43,000-66,000 (12), while the deglycosylated molecule has a molecular weight of around 32,000. In the kidney, two types of basigin were detected: basigin reacting with RCA-I had a molecular weight of 38,000-43,000, while basigin reacting with Con A had a molecular weight of around 30,000. Basigin from the liver, small intestine and spleen had a molecular weight of around 48,000. Thus, glycosylation patterns are different in basigin from different sources. In other words, the glycosylation difference is a factor which can endow tissue specificity to basigin molecules. Further support for the above statement is that, except for renal tubules, the adult organs mentioned above do not express LTA-binding sites (19) , while basigin was found as a carrier of LTAbinding sites in EC cells. Histochemical studies using lectins and monoclonal antibodies have shown that various tissues are differently glycosylated (13) . It is quite possible that basigin carries some of tissue-specified carbohydrate markers in adult tissues, just as it carries a de- tifact. The heterogeneity is probably caused by differential splicing of basigin mRNAat the 5' region. However, it is appropriate to mention that at the present time, we do not knowwhether or not basigin protein with a different N-terminal sequence is actually present. The possibility that a part of the heterogeneity is due to unspliced mRNA is not completely eliminated, but is unlikely considering the frequency of CDNAclones with different structures.
Southern blotting and Northern blotting experiments
suggested the presence of basiginlike molecules in the humanand the hamster. Since considerable species specificity was implicated from the profile of the banding patterns, it becomes necessary to examine how closely basiginlike molecules from different sources are related to mouse basigin. For example, analysis of the human CDNAclone of basigin is required to determine how the humanand the mouse proteins are related. The present report complements the previous one, and considerable information has accumulated on the structure of the newly found cell-surface molecule. The future efforts should be directed to clarifying the function of this molecule. Preparation of large amounts of recombinant basigin is an important step toward this end, and work along this line is now in progress.
